Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2012 · 10-Q
Revenue$3.11B$3.11B+8.9% vs Q2 2011 Net Income$233.80M$233.80M−55.3% vs Q2 2011 EPS Diluted$0.63$0.63−53.7% vs Q2 2011 Gross Profit$1,321,300,000+13.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$507,500,000+43.1% Free Cash Flowderived$442,000,000+46.8% Margins · derivedGross margin42.5%+1.8 pt vs Q2 2011
Operating margin11.8%+2.5 pt vs Q2 2011
Net margin7.5%−10.8 pt vs Q2 2011
ended Jun 30, 2012 · filed Aug 3, 2012 · 34 d after period end